TickerGuard
Buy Day today: Poor (52) Mixed market breadth · today: Core PCE (August) ≈
VYGR

Voyager Therapeutics Inc

Healthcare · Biotechnology

2.80$ -2.4% vs. previous close Closing price · As of: Sep 24, 2026

Statements

Balance Sheet

Voyager Therapeutics Inc (VYGR) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 198 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet VYGR
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
295 351 470 436 426 393 353 322 288 252 219 198
262 320 409 382 373 277 245 228 220 203 147 125
65 69 143 76 113 71 75 44 45 65 43 36
253 231 400 371 345 267 236 216 209 196 141 116
3.3 84 3.5 3.3 20 4.5 2.1 2.5 4.0 1.8 1.6 3.2
– 0.0 0.0 – – – – – – – – –
118 115 129 101 96 93 81 78 68 56 46 43
62 65 73 40 44 50 40 42 35 27 17 17
3.1 3.2 5.9 6.7 7.0 7.2 7.4 7.6 7.8 7.8 7.4 6.9
3.3 1.6 7.6 2.6 3.2 4.0 2.6 1.8 2.1 5.0 2.7 1.6
176 236 341 335 330 300 273 244 220 196 174 154
-318 -261 -273 -283 -292 -326 -357 -391 -418 -446 -474 -498
44 45 57 58 58 58 58 59 59 59 59 61

Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?